TickerFactsScreenerDevelopers

IGC Pharma, Inc. (IGC) — Operating Income

Annual figures by fiscal year, from SEC filings.

2011: -$15.89M2012: -$7.51M2013: -$2.48M2014: -$2.53M2015: -$4.34M2016: -$2.91M2017: -$2.05M2018: -$1.79M2019: -$4.64M2020: -$6.86M2021: -$8.72M2022: -$15.43M2023: -$11.57M2024: -$9.80M2025: -$7.45M-$7.45M
2011Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$7.45M+24.0%
2024-$9.80M+15.3%
2023-$11.57M+25.0%
2022-$15.43M-76.8%
2021-$8.72M-27.1%
2020-$6.86M-47.8%
2019-$4.64M-159.5%
2018-$1.79M+12.9%
2017-$2.05M+29.3%
2016-$2.91M+33.1%
2015-$4.34M-71.8%
2014-$2.53M-1.8%
2013-$2.48M+66.9%
2012-$7.51M+52.7%
2011-$15.89M—